| Literature DB >> 26046909 |
Sirisha Emani1, Aditya K Kaza2, Melvin Almodovar3, Ravi Thiagarajan3, Sitaram M Emani2.
Abstract
Thrombosis occurs after aortopulmonary shunting in children despite the use of heparin and oral antiplatelet agents. We describe the use of an intravenous antiplatelet agent for secondary prevention of shunt thrombosis without adverse events. Platelet mapping was used to monitor the effects and demonstrated the rapid onset of platelet inhibition.Entities:
Mesh：
Substances：
Year: 2015 PMID： 26046909 DOI： 10.1016/j.athoracsur.2015.02.103
Source DB: PubMed Journal: Ann Thorac Surg ISSN： 0003-4975 Impact factor: 4.330